首页> 美国卫生研究院文献>International Journal of Oncology >MicroRNA-98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k-Ras/Raf/MEK/ERK signaling pathway
【2h】

MicroRNA-98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k-Ras/Raf/MEK/ERK signaling pathway

机译:MicroRNA-98通过靶向IGF1R / k-Ras / Raf / MEK / ERK信号通路抑制视网膜母细胞瘤的细胞生长和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Accumulating evidence has indicated that the dysregulation of microRNAs (miRNAs) is involved in the pathogenesis o retinoblastoma (RB); however, the potential role of miR-98 in RB remains elusive. In the present study, it was demonstrated that miR-98 is downregulated in RB tissues and cell lines, and its expression significantly associated with clinicopathological features, including differentiation, N classification and largest tumor base; patients with low miR-98 expression levels exhibited significantly poorer overall survival. Overexpression of miR-98 was suggested to suppress RB cell growth, migration and invasion. In addition, insulin-like growth factor-1 receptor (IGF1R), a well-reported oncogene, was identified as a potential target of miR-98 via a luciferase assay, reverse transcription-quantitative polymerase chain reaction and western blotting. Correlation analysis revealed a significantly negative correlation between miR-98 and IGF1R expression in tumor tissues (n=60). In addition, the results of the present study demonstrated that IGF1R function as an oncogene by promoting RB cell viability, migration and invasion. Furthermore, restoration of IGF1R was observed to reverse the anticancer effects of miR-98 on RB cell viability, migration and invasion. Importantly, the findings of the present study indicated that miR-98 suppressed RB cell growth and metastasis by inhibiting the IGF1R/k-Ras/Raf/mitogen activated protein kinase kinase/extracellular signal-regulated kinase signaling pathway. Collectively, the present study proposed that miR-98 may serve as a novel prognostic biomarker and therapeutic target in the treatment of RB.
机译:越来越多的证据表明,微小RNA(miRNA)的失调与视网膜母细胞瘤(RB)的发病有关。但是,miR-98在RB中的潜在作用仍然难以捉摸。在本研究中,已证明miR-98在RB组织和细胞系中被下调,其表达与临床病理特征显着相关,包括分化,N分类和最大的肿瘤碱基。 miR-98表达水平低的患者总体生存率显着降低。建议miR-98的过表达抑制RB细胞的生长,迁移和侵袭。此外,通过荧光素酶测定,逆转录定量聚合酶链反应和蛋白质印迹,胰岛素受体样生长因子-1受体(IGF1R)(一种报道广泛的癌基因)被确定为miR-98的潜在靶标。相关分析显示,肿瘤组织中miR-98和IGF1R表达之间显着负相关(n = 60)。另外,本研究的结果表明IGF1R通过促进RB细胞的活力,迁移和侵袭而作为癌基因起作用。此外,观察到IGF1R的恢复可逆转miR-98对RB细胞活力,迁移和侵袭的抗癌作用。重要的是,本研究的发现表明,miR-98通过抑制IGF1R / k-Ras / Raf /有丝分裂原激活的蛋白激酶激酶/细胞外信号调节激酶的信号传导途径来抑制RB细胞的生长和转移。总体而言,本研究提出miR-98可以作为RB治疗中的一种新的预后生物标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号